Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Cloix

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Neuroscience|June 29, 2010
Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonistM Picard, S Morisset, J F Cloix, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Recent advances on endogenous Na+,K+-ATPase inhibitors: clinical investigation and purificationJ F Cloix, M A Devynck, I W Wainer, et al.
Journal De Physiologie|January 1, 1984
Clinical and biochemical approach of a circulating Na+-pump inhibitorM A Devynck, H de The, M G Pernollet, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1984
Circulating digitalis-like compounds in essential hypertensionM A Devynck, M G Pernollet, J F Cloix, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Investigation of the endogenous Na+-pump inhibitor in essential hypertension and blood volume expansionM A Devynck, M G Pernollet, G Deray, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1983
Plasma endogenous sodium pump inhibitor in essential hypertensionJ F Cloix, M A Devynck, J L Elghozi, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1985
Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertensionJ F Cloix, M Crabos, M A Devynck, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Neuroscience|June 29, 2010
Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonistM Picard, S Morisset, J F Cloix, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Recent advances on endogenous Na+,K+-ATPase inhibitors: clinical investigation and purificationJ F Cloix, M A Devynck, I W Wainer, et al.
Journal De Physiologie|January 1, 1984
Clinical and biochemical approach of a circulating Na+-pump inhibitorM A Devynck, H de The, M G Pernollet, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1984
Circulating digitalis-like compounds in essential hypertensionM A Devynck, M G Pernollet, J F Cloix, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Investigation of the endogenous Na+-pump inhibitor in essential hypertension and blood volume expansionM A Devynck, M G Pernollet, G Deray, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1983
Plasma endogenous sodium pump inhibitor in essential hypertensionJ F Cloix, M A Devynck, J L Elghozi, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1985
Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertensionJ F Cloix, M Crabos, M A Devynck, et al.
Pageof 6